Results 171 to 180 of about 2,285,544 (373)
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Using student‐centered approaches to teach the biochemistry of
Maha Zewail‐Foote
openalex +1 more source
Retraction: Beyond the Curriculum: Exploring Perception of Equity, Diversity, and Inclusion Among Medical Students. [PDF]
Alsaleh RA +3 more
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
The biochemistry of organotin compounds Trialkyltins and oxidative phosphorylation [PDF]
W.N. Aldridge
openalex +1 more source
Correction: Rapidly decellularized adipose tissue induces soft tissue vascularization in potential anatomical spaces. [PDF]
Piejko M +7 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Phytase and xylanase in diets with nutritional adjustments and their effects on serum biochemistry, morphometry and intestinal health of broilers [PDF]
Natália Ramos Batista Chaves +11 more
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source

